Advertisement
  • Loading metrics

Neurosyphilis in Africa: A systematic review

  • Michael Marks ,

    Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

    Michael.marks@lshtm.ac.uk

    Affiliations Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom, Hospital for Tropical Diseases, Mortimer Market Centre, London, United Kingdom

  • Joseph N. Jarvis,

    Roles Formal analysis, Writing – review & editing

    Affiliations Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom, Hospital for Tropical Diseases, Mortimer Market Centre, London, United Kingdom, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, United States of America

  • William Howlett,

    Roles Formal analysis, Writing – review & editing

    Affiliation Kilimanjaro Christian Medical Centre, Moshi, Tanzania

  • David C. W. Mabey

    Roles Conceptualization, Writing – review & editing

    Affiliations Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom, Hospital for Tropical Diseases, Mortimer Market Centre, London, United Kingdom

Neurosyphilis in Africa: A systematic review

  • Michael Marks, 
  • Joseph N. Jarvis, 
  • William Howlett, 
  • David C. W. Mabey
PLOS
x

Abstract

Introduction

Neurological involvement is one of the most important clinical manifestations of syphilis and neurological disease occurs in both early and late syphilis. The impact of HIV co-infection on clinical neurosyphilis remains unclear. The highest prevalence of both syphilis and HIV is in Africa. Therefore it might be expected that neurosyphilis would be an important and not uncommon manifestation of syphilis in Africa and frequently occur in association with HIV co-infection; yet few data are available on neurosyphilis in Africa. The aim of this study is to review data on neurosyphilis in Africa since the onset of the HIV epidemic.

Methods

We searched the literature for references on neurosyphilis in Africa for studies published between the 1st of January 1990 and 15th February 2017. We included case reports, case series, and retrospective and prospective cohort and case-control studies. We did not limit inclusion based on the diagnostic criteria used for neurosyphilis. For retrospective and prospective cohorts, we calculated the proportion of study participants who were diagnosed with neurosyphilis according to the individual study criteria. Depending on the study, we assessed the proportion of patients with syphilis found to have neurosyphilis, and the proportion of patients with neurological syndromes who had neurosyphilis. Due to heterogeneity of data no formal pooling of the data or meta-analysis was undertaken.

Results

Amongst patients presenting with a neurological syndrome, three studies of patients with meningitis were identified; neurosyphilis was consistently reported to cause approximately 3% of all cases. Three studies on stroke reported mixed findings but were limited due to the small number of patients undergoing CSF examination, whilst neurosyphilis continued to be reported as a common cause of dementia in studies from North Africa. Ten studies reported on cases of neurosyphilis amongst patients known to have syphilis. Studies from both North and Southern Africa continue to report cases of late stage syphilis, including tabes dorsalis and neurosyphilis, in association with ocular disease.

Discussion

This is the first systematic review of the literature on neurosyphilis in Africa since the beginning of the HIV epidemic. Neurosyphilis continues to be reported as a manifestation of both early and late syphilis, but the methodological quality of the majority of the included studies was poor. Future well-designed prospective studies are needed to better delineate the incidence and clinical spectrum of neurosyphilis in Africa and to better define interactions with HIV in this setting.

Author summary

Involvement of the central nervous system is an important manifestation of syphilis which may be more common in patients co-infected with HIV. As most cases of syphilis and HIV are seen in Africa it might be anticipated that neurosyphilis was common there. We reviewed all published material on neurosyphilis in Africa since 1990. There were few well designed studies of neurosyphilis. A small number of studies suggested that syphilis remains a cause of meningitis in Africa. Our data suggest that neuosyphilis remains an important disease in Africa but better prospective studies are needed to understand its epidemiology.

Introduction

Syphilis, caused by Treponema pallidum subsp. pallidum, remains an important sexually transmitted disease worldwide. Some studies suggest the natural history, outcomes of treatment, and likelihood of central nervous system involvement are different in HIV-infected compared to uninfected individuals [13], but consensus has not been reached [4]. Globally the highest rates of syphilis and HIV are in Africa[5]. Based on this and the potential for interaction with HIV in the region, it might be expected that neurosyphilis would be an important and not uncommon manifestation of syphilis in Africa, yet few data are available.

Neurological involvement is one of the most important manifestations of syphilis. Typically neurosyphilis is described as a late manifestation, but neuroinvasion and neurological disease occur in both early and late syphilis[6], and T.pallidum may be frequently identified in the CSF of patients with early stage syphilis[7]. The clinical spectrum seen ranges from asymptomatic neuroinvasion, meningitis, meningovascular disease presenting as a stroke-like syndrome, and the late stage manifestations of tertiary syphilis: tabes dorsalis and general paresis of the insane[8].

Cerebrospinal fluid (CSF) is frequently abnormal in patients with neurosyphilis with both pleocytosis and raised protein concentration. The Venereal Disease Research Laboratory (VDRL) assay on CSF is normally considered the gold standard for specificity, but is recognised to have limited sensitivity [9,10]. Other CSF tests, including serological assays, such as the Rapid Plasma Reagin (RPR)[11], Fluorescent Treponemal Antibody-adsorption (FTA-ABS)[12] and Treponema pallidum haemagglutination assay[13]and molecular assays including PCR[14] have all been assessed for CSF and have variable specificity and sensitivity for the diagnosis of neurosyphilis. Difficulties in interpretation of CSF pleocytosis in individuals co-infected with HIV add to challenges in evaluating the relationship between the two diseases. CSF pleocytosis is seen in individuals with either infection alone [4,14], thus discerning the cause of pleocytosis in co-infected individuals is not possible.

The aim of this study is to review data on neurosyphilis in Africa since the onset of the HIV epidemic.

Methods

Search strategy and selection criteria

We searched Pubmed, Medline, EMBASE and the grey literature for references on neurosyphilis in Africa. We searched reference lists of selected papers to identify additional references. We searched for (“CSF” OR “lumbar puncture” OR “meningitis” OR “meningovascular” OR “stroke”) AND “syphilis”) OR (“neurosyphilis” OR “tabes dorsalis” OR “general paresis”) AND (Africa OR each individual country in Africa). We limited the search to studies published between 1st of January 1990 and 15th February 2017 (the date the search was conducted). No language restrictions were placed. We excluded reviews if they did not report new primary material, studies limited purely to comparisons of diagnostic techniques, studies on non-neurological manifestations of syphilis, studies reporting cases occurring before 1990, and studies reporting patients already described in a different paper.

Data extraction

For each reference we extracted the number of sites in each study, the duration of the study, inclusion and exclusion criteria, diagnostic criteria for neurosyphilis, the clinical syndromes, and the number of HIV infected and uninfected individuals. We also extracted information on the treatment and outcomes of patients in these studies.

Statistical analysis

For retrospective and prospective cohorts, we calculated the proportion of study participants who were diagnosed with neurosyphilis according to the individual study criteria. Depending on the study, we assessed the proportion of patients with syphilis found to have neurosyphilis, and the proportion of patients with neurological syndromes who had neurosyphilis. Due to heterogeneity of data no formal pooling of the data or meta-analysis was undertaken.

Results

We identified 189 citations of which 42 met our inclusion criteria (Fig 1) (Tables 13).

thumbnail
Table 1. Case reports of neurosyphilis—Clinical and diagnostic features.

https://doi.org/10.1371/journal.pntd.0005880.t001

thumbnail
Table 2. Patients presenting with neurological syndromes—Inclusion criteria, clinical and diagnostic features.

https://doi.org/10.1371/journal.pntd.0005880.t002

thumbnail
Table 3. Patients with syphilis investigated for neurosyphilis—Inclusion criteria, clinical and diagnostic features.

https://doi.org/10.1371/journal.pntd.0005880.t003

Case reports

Twenty-one case reports including 37 patients were identified [1535]. The clinical syndromes included focal neurological manifestations such as cranial nerve involvement and including range of manifestations including meningitis, meningovascular syphilis, tabes dorsalis and dementia (Table 1).

Patients presenting with a neurological syndrome

Eleven studies reported data on patients presenting with neurological syndromes (Table 2). The methodological quality of many of these studies was poor (Table 4). At least one major methodological limitation was identified in half. Six studies were retrospective (54.5%) and only eight (72.7%) included the performance of lumbar punctures to make the diagnosis of neurosyphilis. Several studies did not provide clear diagnostic criteria for neurosyphilis and, even in studies where LP was performed, it was frequently not performed on all patients enrolled in the study.

thumbnail
Table 4. Methodological assessment of criteria used for diagnosis of neurosyphilis.

https://doi.org/10.1371/journal.pntd.0005880.t004

Dementia.

In a single-centre retrospective study from Morocco of 563 patients attending a dementia clinic between 2000–2013 neurosyphilis was reported to be the most common infectious cause of dementia identified, and accounted for 3.6% of all cases of dementia seen during the study period[36]. Details on CSF diagnostics were not provided, so the proportion of these cases which were definitive neurosyphilis is not known.

Seizures.

A retrospective study in Ethiopia of individuals aged over 13 presenting with status epilepticus enrolled a total of 119 patients but only 25 (21%) patients underwent CSF testing for neurosyphilis[37]. In this subgroup a diagnosis of neurosyphilis was made in 2 patients on the basis of a positive CSF VDRL (8%).

In a prospective study in Zambia[38], HIV infected patients with a new onset of seizures were enrolled and underwent CSF testing within two weeks of the index seizure. Three patients had a reactive serum RPR and TPHA, but no individual had a positive CSF VDRL.

Stroke.

In a retrospective study from Morocco of adults aged 18–45 (n = 128) presenting with stroke the underlying diagnosis was reported to be meningovascular syphilis in 14 patients (11%). However CSF diagnostics were not undertaken and syphilis was diagnosed on the basis of serum serological testing, so the proportion of these cases which were definitive neurosyphilis is unknown. [39].

Two prospective studies conducted in Malawi and Sudan enrolled patients presenting with stroke (n = 98 and n = 96 respectively)[40,41]. Lumbar punctures were performed and a positive CSF VDRL was considered diagnostic in both studies. In the study in Malawi [40] 48% of patients were HIV positive. Fifty nine individuals had serum syphilis serology performed. Thirteen patients had a positive TPPA and a negative VDRL and a further five patients had both a positive TPPA and a VDRL. CSF VDRL testing was negative in all patients with positive serological tests on blood. In the study in Sudan both serological and CSF evidence of syphilis were assessed and a positive CSF-VDRL was considered diagnostic of neurosyphilis [41]. The prevalence of HIV was not stated for patients enrolled in the study. Syphilis was identified as the major risk factor for stroke in four patients (4.2%) but no details were given as to whether this was based on serum testing alone or on CSF testing.

A case-control study of stroke conducted in Tanzania between 2003–2006 enrolled 158 stroke cases and 369 age- and sex- matched controls[42]. Serology for syphilis was performed using an IgG ELISA (Treponema pallidum IgG ELISA; IBL international GmbH, Hamburg, Germany). The seroprevalence was significantly higher in stroke cases (24.7%) compared to controls (12.7%) and a positive ELISA was associated with a significantly increased risk of stroke (OR 2.8, 95% CI 1.6–4.6). No CSF testing was performed in this study so it is not clear whether this association represents causation and, if so, whether the mechanism is meningovascular syphilis.

Meningitis.

Prospective and retrospective studies in South Africa, and a further prospective study in Uganda, enrolled patients with clinically suspected meningitis. In the prospective South African study, sixty consecutive patients with clinically suspected meningitis were enrolled[43]. The overall seroprevalence for HIV was 68%. Of the 60 enrolled patients a microbiological diagnosis was made in 39 (65%). Meningococcal meningitis accounted for ten cases. Tuberculous meningitis and cryptococcal meningitis each accounted for nine cases. On the basis of a positive CSF RPR and TPHA two cases of neurosyphilis were diagnosed (3.3%)–one with an oculomotor nerve palsy and one with cryptococcal co-infection.

In the retrospective study from South Africa[44], 4,961 episodes of suspected meningitis were included. Neurosyphilis was diagnosed on the basis of a reactive CSF TPHA or VDRL. Of the total population studied, 2,293 were found to have normal CSF and a further 931 patients were found to have changes compatible with HIV alone. Of the 1,737 individuals who had an LP compatible with meningitis a microbiological diagnosis was made in 820 patients (47%). A diagnosis of neurosyphilis was made in 22 patients (1.26% of patients with an abnormal CSF, 3% of patients with a microbiological diagnosis). Testing for neurosyphilis was performed at the physician’s discretion and this is likely to be an underestimate of the true proportion of cases caused by neurosyphilis.

In Uganda samples were obtained from patients enrolled in a study ART initiation in HIV positive patients with cryptococcal meningitis [45]. A total of 63 patients negative for Cryptococcus in CSF and 54 patients with Cryptococcal meningitis were assessed. The overall syphilis seroprevalence in these patients was not stated but neurosyphilis was diagnosed in 3 of 111 (2.7%) patients who were tested on the basis of a positive CSF VDRL, accounting for a comparable number of cases as bacterial meningitis (Streptococcus pneumoniae n = 4, Neisseria meningitidis n = 1).

Other.

In a study conducted at a single site in Uganda and a single site in Kenya, a total of 288 consecutive patients with neurological symptoms were enrolled[46]. All patients underwent a neurological examination but detailed information was not provided on the clinical abnormalities seen. The overall prevalence of HIV was 12.2%. A total of 87 patients underwent CSF testing. Neurosyphilis was the diagnosis in 32 (11.1%) although the proportion of patients who had a diagnosis based on a positive CSF test was not reported, nor was the overall prevalence of syphilis in the study population given.

Studies on neurosyphilis amongst patients with syphilis

Ten studies reported on cases of neurosyphilis amongst patients known to have syphilis (Table 3). The methodological quality of many studies was poor with at least one significant methodological weakness in all but one study (Table 4). The study design was retrospective for six of the studies (60%) whilst lumbar puncture was performed in only seven studies (70%) for the diagnosis of neurosyphilis but, of these, only five studies (50%) stated what assay was used.

Suspected neurosyphilis.

Two retrospective studies from Morocco reported on a total of 256 patients clinically suspected to have neurosyphilis [47,48]. In the larger study (n = 201), neurosyphilis was diagnosed based on a positive CSF VDRL and TPHA. In the smaller study (n = 55) the authors report patients had a positive CSF serological test for neurosyphilis but do not provide details on which tests were performed. Dementia was the most commonly clinical syndrome seen in 56.6% patients (n = 145) followed by meningovascular syphilis (n = 65, 25.4%) and tabes dorsalis (n = 29, 11.3%).

A further retrospective study from Morocco included 24 patients with arthropathy suspected to be due to tabes dorsalis. CSF testing was performed using a test for treponemal antibodies but the precise test was not stated. In this study all patients had positive syphilis serology on serum while 33.3% of patients had positive CSF serology [49].

A retrospective study from South Africa included patients with neurosyphilis diagnosed on the basis of a positive CSF FTA-ABS seen in a single hospital in the Western Cape region over a ten-year period. A total of 161 patients were identified. Dementia was the most common diagnosis (n = 81, 50.9%), followed by meningovascular syphilis (n = 24, 14.9%)[50].

In a prospective study in South Africa[51], 50 patients with suspected neurosyphilis were enrolled. All patients were seropositive for syphilis and clinically diagnosed with tertiary neurosyphilis although detailed clinical information was not provided. All underwent lumbar puncture. Forty patients (80%) had reactive CSF serology (70% VDRL and FTA-ABS, 10% FTA-ABS alone) and a further 5 patients (10%) had a positive CSF PCR but negative CSF serology.

Finally, a case-series from a single centre in Guinea reported 28 patients who were diagnosed with neurosyphilis on the basis of both a positive CSF VDRL and CSF-TPHA [52]. The series included a broad spectrum of neurological presentations including three cases of facial nerve palsy, four cases of optic atrophy, eleven cases of seizures, three cases of cerebellar ataxia, two cases of vestibular-cochlear nerve dysfunction and five cases of clinical meningitis.

Ocular syphilis.

A retrospective study from South Africa included patients clinically diagnosed with ocular syphilis (n = 68), all of whom had positive serum serology results. Four cases were known to be HIV positive, one HIV negative, and the status was unknown for the remaining three cases. Thirty-one (45.6%) patients underwent lumbar puncture (not all of whom had CSF serologica testing) and, of these, a quarter (n = 8) had CSF findings felt to be consistent with neurosyphilis [53]. In five cases this was a reactive CSF FTA-ABS and, in three cases, this was a CSF lymphocyic pleocytosis.

Individuals with HIV and syphilis co-infection.

Three studies were identified reporting on the prevalence of neurosyphilis in individuals with HIV. In a study assessing treatment of HIV co-infected individuals in Mozambique[54], twenty-one patients with latent syphilis underwent lumbar puncture at baseline. Four patients (19%) were diagnosed with asymptomatic neurosyphilis. None had a positive CSF RPR, all had elevated CSF protein and two had a CSF pleocytosis (WBC > 5/mm3). As all patients were co-infected with HIV the significance of a pleocystosis greater than 5/mm3 is uncertain. All patients were re-examined at 3, 6 and 12 months. At six months follow-up one patient still had an abnormal CSF (elevated protein and pleocyosis) but no patients had an abnormal CSF by twelve months.

In a study conducted between 2000 and 2001, 31 patients with syphilis and HIV co-infection were seen at a dermatology clinic in Nigeria. All had early syphilis (primary syphilis = 9, secondary syphilis = 20 and latent syphilis = 2). The authors report that no cases of neurosyphilis were seen, but details are not provided on what proportion of patients underwent CSF examination[55].

Finally, in a study of 506 consecutive HIV infected patients in Johannesburg only one case of neurosyphilis was identified [56], but neither the prevalence of syphilis nor the number of patients who underwent lumbar puncture is given, so the interpretation of this finding is extremely limited.

Diagnostic criteria

CSF diagnostic criteria varied across studies (Table 4). The most commonly used criteria were CSF VDRL alone (n = 14 studies) followed by CSF VDRL combined with either a CSF TPHA (n = 9 studies) or FTA-ABS (n = 2 studies). Two studies defined neurosyphilis as reactive CSF FTA-ABS with or without pleocytosis and two studies used the RPR and TPHA assays on CSF. One study defined neurosyphilis as any one of an abnormal CSF protein, white cell count or CSF RPR assay. Ten studies stated that CSF was tested using serological assays but did not clearly state which diagnostic test was used.

Discussion

This is the first systematic review of the literature on neurosyphilis in Africa. The methodological quality of the majority of the studies was poor and as such limited conclusions can be drawn. The available data are clearly inadequate data to robustly estimate the prevalence of neurosyphilis in Africa or the proportion of cases of important neurological syndromes due to neurosyphilis. The data are also inadequate to address any potential interaction between HIV and syphilis in this setting.

Whilst HIV has been reported in Africa since the 1980s we restricted our search to papers published after 1990. By this point the HIV epidemic was fully established and any impact of HIV on the risk of neurosyphilis might be anticipated o have become apparent. Whilst we used comprehensive search and MESH terms to identify papers it is possible that some studies on oto-syphilis or other forms of neurosyphilis, or studies which did not explicitly mention Africa (or an African country) might have been missed. Despite these limitations, we believe our comprehensive search strategy is likely to have identified nearly all the relevant research papers for this systematic review.

A major methodological failing of many studies was an inadequate approach to diagnostic criteria for neurosyphilis. A number of studies included only serum testing without CSF examination, whilst others did not adequately report the specific CSF assay performed. In part, this may reflect the lack of an adequate gold-standard. There is a clear need to better define standards for use in routine diagnosis in low-resource settings, but also for use in research studies.

The studies on patients presenting with stroke are all limited by methodological weaknesses. Across these studies there appears to be a consistent association between positive serum syphilis serology and stroke but, as only a minority of studies undertook CSF examination, these studies are difficult to interpret, and whether this reflects neurosyphilis is uncertain. It is possible that the association truly reflects meningovascular syphilis, emboli due to cardiovascular syphilis, or confounding factors. Further studies are needed to better delineate the role of syphilis as a cause of stroke in Africa.

Studies from Morocco continue to report late-stage neurosyphilis, but the majority of studies are of low methodological quality. In comparison there appear to be few cases of tertiary neurosyphilis reported from sub-Saharan Africa. Given the weaknesses of most of the studies it is extremely uncertain whether this represents a true difference in the frequency of tertiary neurosyphilis or simply reflects reporting/publication bias or lack of access to medical resources for diagnosis. It has been hypothesised that the ease of access to short courses of penicillin in the community may have altered the natural history of syphilis, resulting in a lower frequency of late stage manifestations, but this would not explain why cases continue to be seen in North Africa but not sub-Saharan Africa.

There was a small number of higher quality prospective studies enrolling patients with suspected meningitis, in which neurosyphilis was identified [43,45]. These studies had clear inclusion criteria, included adequate data on denominators, and clear diagnostic criteria for neurosyphilis. In these studies the prevalence of neurosyphilis was approximately 3%. In these studies the frequency of neurosyphilis was similar to that of S.pneumoniae as a cause of meningitis, which likely reflects that patients predominantly had subacute meningitis. This would make syphilis an important and treatable cause of meningitis in Africa. Given the limitations of CSF serological assays, it is likely that the true proportion of meningitis due to neurosyphilis is higher.

The clinical epidemiology of neurosyphilis in Africa remains poorly understood and the majority of studies included in this review were of low methodological quality. Inadequate diagnostics remain a major barrier to progress in our understanding of these important diseases. Future well-designed prospective studies are needed to better delineate the incidence and clinical spectrum of neurosyphilis in Africa.

Supporting information

Acknowledgments

Many thanks to Professor Christina Marra and Professor Sheila Lukehart for their critical review and comments.

References

  1. 1. Berry CD, Hooton TM, Collier AC, Lukehart SA. Neurologic Relapse after Benzathine Penicillin Therapy for Secondary Syphilis in a Patient with HIV Infection. N Engl J Med. 1987;316: 1587–1589. pmid:3587291
  2. 2. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med. 1987;316: 1569–1572. pmid:3587290
  3. 3. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A Randomized Trial of Enhanced Therapy for Early Syphilis in Patients with and without Human Immunodeficiency Virus Infection. N Engl J Med. 1997;337: 307–314. pmid:9235493
  4. 4. Rompalo AM, Joesoef MR, O’Donnell JA, Augenbraun MH, Brady W, Radolf JD, et al. Clinical Manifestations of Early Syphilis by HIV Status and Gender: Results of the Syphilis and HIV Study. Sex Transm Dis March 2001. 2001;28: 158–165.
  5. 5. Organization WH. Report on global sexually transmitted infection surveillance 2015 [Internet]. World Health Organization; 2016. http://www.who.int/iris/handle/10665/249553
  6. 6. Golden MR, Marra CM, Holmes KK. Update on Syphilis: Resurgence of an Old Problem. JAMA. 2003;290: 1510–1514. pmid:13129993
  7. 7. Lukehart SA, Hook EW, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med. 1988;109: 855–862. pmid:3056164
  8. 8. Hook EW. Syphilis. The Lancet. 2017;389: 1550–1557.
  9. 9. Ghanem KG, Workowski KA. Management of Adult Syphilis. Clin Infect Dis. 2011;53: S110–S128. pmid:22080265
  10. 10. Kingston M, French P, Higgins S, McQuillan O, Sukthankar A, Stott C, et al. UK national guidelines on the management of syphilis 2015. Int J STD AIDS. 2016;27: 421–446. pmid:26721608
  11. 11. Marra CM, Tantalo LC, Maxwell CL, Ho EL, Sahi SK, Jones T. The Rapid Plasma Reagin Test Cannot Replace the Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis. Sex Transm Dis. 2012;39: 453–457. pmid:22592831
  12. 12. Marra CM, Tantalo LC, Maxwell CL, Dougherty K, Wood B. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology. 2004;63: 85–88. pmid:15249615
  13. 13. Marra CM, Maxwell CL, Dunaway SB, Sahi SK, Tantalo LC. Cerebrospinal Fluid Treponema pallidum Particle Agglutination Assay for Neurosyphilis Diagnosis. J Clin Microbiol. 2017;55: 1865–1870. pmid:28381602
  14. 14. Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, Eaton M, et al. Cerebrospinal Fluid Abnormalities in Patients with Syphilis: Association with Clinical and Laboratory Features. J Infect Dis. 2004;189: 369–376. pmid:14745693
  15. 15. Wolf B, Kalangu K. Congenital neurosyphilis revisited. Eur J Pediatr. 1993;152: 493–495. pmid:8335016
  16. 16. Silber E, Sonnenberg P, Koornhof HJ, Morris L, Saffer D. Dual infective pathology in patients with cryptococcal meningitis. Neurology. 1998;51: 1213–1215. pmid:9781566
  17. 17. Bulundwe KK, Myburgh CJ, Gledhill RF. Syringomyelia complicating syphilitic spinal meningitis: a case report. Eur J Neurol. 2000;7: 231–236. pmid:10809948
  18. 18. Nunes da Silva MJ, Oliveira V, Sousa AE, Lucas M, Victorino RM. [Headaches, otalgia and peripheral facial palsy as a form of presentation of neurosyphilis]. Rev Neurol. 2000;31: 544–546. pmid:11055060
  19. 19. Seydi M, N’Diaye M, Dia NM, Soumaré M, N’Dour CT, Dieng Y, et al. [Cryptococcal meningitis and positive syphilitic serology in a patient infected by HIV]. Dakar Med. 2001;46: 65–67. pmid:15773162
  20. 20. Corr P, Bhigjee A, Lockhat F. Oculomotor nerve root enhancement in meningovascular syphilis. Clin Radiol. 2004;59: 294–296. pmid:15037145
  21. 21. Zouhair K, Akhdari N, El Ouazzani T, Lazrak S, Lakhdar H. Arthropathie tabétique : « une maladie oubliée ». Ann Dermatol Vénéréologie. 2004;131: 787–789.
  22. 22. Harifi G, Louhab N, Kissani N. [Trigeminal neuralgia revealing neurosyphilis]. Rev Neurol (Paris). 2009;165: 988–990. pmid:19592059
  23. 23. Salami AK, Isa MB. HIV-associated neurosyphilis: report of a fatal case due to fear of work-place stigma. Ann Afr Med. 2009;8: 192–195. pmid:19884699
  24. 24. Mrabet D, Monastiri I, Sahli H, Nouira K, Farhat S, Chéour E, et al. [Chronic hydarthrosis of the knee in a Tunisian patient: tabetic arthropathy]. Med Trop Rev Corps Sante Colon. 2010;70: 537–539.
  25. 25. Kyebambe PS. Neurosyphilis masquerading as hemiparesis and Jacksonian epilepsy in an HIV positive patient: a case report. Afr Health Sci. 2010;10: 211–214. pmid:21326980
  26. 26. Wasserman S, Vallie Y, Bryer A. The great pretender. Lancet Lond Engl. 2011;377: 1976.
  27. 27. Mebrouk Y, Chraa M, McMaughey C, Kissani N. Syringomyelia associated with syphilitic spinal meningitis: real complication or possible association? Spinal Cord. 2011;49: 757–760. pmid:21339760
  28. 28. Napon C, Maïga Y, Kaboré J. [Hemiballism in relation with neurosyphilis in Burkina Faso]. Rev Neurol (Paris). 2012;168: 989–990. pmid:22682051
  29. 29. Derouich I, Messouak O, Belahsen MF. Syphilitic limbic encephalitis revealed by status epilepticus. BMJ Case Rep. 2013;2013. pmid:23391954
  30. 30. Samia M, Ezzahra AF, Khadija B, Nadira K, Latifa T, Taoufik H. Bilateral neuro-arthropathy of the ankle as a sequela of undiagnosed tabes dorsalis. Jt Bone Spine Rev Rhum. 2013;80: 664. pmid:23623735
  31. 31. Lakjiri S, Mernissi FZ. Tabetic arthropathy revealing neurosyphilis: a new observation. Pan Afr Med J. 2014;18: 198. pmid:25419325
  32. 32. Moolla Y, Abdul J. Revisiting an old foe: The face of psychosis in neurosyphilis. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 2016;106: 1186–1187.
  33. 33. Hajjaj I, Kissani N. Status epilepticus revealing syphilitic meningoencephalitis. Acta Neurol Belg. 2010;110: 263–267. pmid:21114135
  34. 34. Bourazza A, Kerouache A, Reda R, Mounach J, Mosseddaq R. [Meningovascular syphilis: study of five cases]. Rev Neurol (Paris). 2008;164: 369–373. pmid:18439929
  35. 35. Hsaini Y, Karouache A, El Kharras A, Darbi A, Bourazza A. [Juvenile tabes arthropathy: a report of three cases]. Ann Biol Clin (Paris). 2010;68: 495–498. pmid:20650747
  36. 36. Benabdeljili M, Essahli N, Rahmani M, Aidi S, Aloui Faris E. Infectious dementias. Experience of the Memory centre of Rabat. European Journal of Neurology. 2016. pp. 111–344.
  37. 37. Amare A, Zenebe G, Hammack J, Davey G. Status epilepticus: Clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients. Epilepsia. 2008;49: 600–607. pmid:18325017
  38. 38. Siddiqi OK, Elafros MA, Bositis CM, Koralnik IJ, Theodore WH, Okulicz JF, et al. New-onset seizure in HIV-infected adult Zambians A search for causes and consequences. Neurology. 2016; pmid:28003499
  39. 39. Chraa M, Louhab N, Kissani N. Stroke in young adults: about 128 cases. Pan Afr Med J. 2014;17: 37. pmid:24932348
  40. 40. Kumwenda JJ, Mateyu G, Kampondeni S, van Dam AP, van Lieshout L, Zijlstra EE. Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Malawi Med J J Med Assoc Malawi. 2005;17: 107–111.
  41. 41. Sokrab T-EO, Sid-Ahmed FM, Idris MNA. Acute stroke type, risk factors, and early outcome in a developing country: a view from Sudan using a hospital-based sample. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2002;11: 63–65. pmid:17903858
  42. 42. de Mast Q, Molhoek JE, van der Ven AJ, Gray WK, de Groot PG, Jusabani A, et al. Antiphospholipid Antibodies and the Risk of Stroke in Urban and Rural Tanzania: A Community-Based Case-Control Study. Stroke. 2016;47: 2589–2595. pmid:27625376
  43. 43. Silber E, Sonnenberg P, Ho KC, Koornhof HJ, Eintracht S, Morris L, et al. Meningitis in a community with a high prevalence of tuberculosis and HIV infection. J Neurol Sci. 1999;162: 20–26. pmid:10064164
  44. 44. Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis. 2010;10: 67. pmid:20230635
  45. 45. Rajasingham R, Rhein J, Klammer K, Musubire A, Nabeta H, Akampurira A, et al. Epidemiology of Meningitis in an HIV-Infected Ugandan Cohort. Am J Trop Med Hyg. 2015;92: 274–279. pmid:25385864
  46. 46. Szabo I, Kulkova N, Sokolova J, Mikolasova G, Suvada J, Kalavska A, et al. Neurologic complications and sequellae of infectious diseases in Uganda and Kenya: Analysis of 288 cases from two rural hospitals. Neuro Endocrinol Lett. 2013;34: 28–31. pmid:24013603
  47. 47. Yahyaoui M, Serragui S, Regragui W, Errguig L, Mouti O, Benomar A, et al. [Epidemiological and clinical aspects of neurosyphilis in Morocco]. East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit. 2005;11: 470–477.
  48. 48. Rafai M., Oumari S, Benmansour Y, Ibnmoufti R, Ibnkhribchia R, Boulaajaj F, et al. Neurosyphilis: clinical aspects, CSF, radiological finding, treatment and outcome: a Moroccan series. European Journal of Neurology. 2012. pp. 458–807.
  49. 49. Allali F, Rahmouni R, Hajjaj-Hassouni N. Tabetic arthropathy. A report of 43 cases. Clin Rheumatol. 2006;25: 858–860. pmid:16601917
  50. 50. Timmermans M, Carr J. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry. 2004;75: 1727–1730. pmid:15548491
  51. 51. Molepo J, Pillay A, Weber B, Morse SA, Hoosen AA. Molecular typing of Treponema pallidum strains from patients with neurosyphilis in Pretoria, South Africa. Sex Transm Infect. 2007;83: 189–192. pmid:17244664
  52. 52. Cisse A, Souare IS, Larkhis S, Cisse B, Beavogui K, Morel Y, et al. [Atypical neurosyphilis: 28 cases observed at the University Hospital Center of Conakry]. Med Trop Rev Corps Sante Colon. 2002;62: 150–154.
  53. 53. Reekie I, Reddy Y. Use of Lumbar Punctures in the Management of Ocular Syphilis. Semin Ophthalmol. 2016; 1–4. pmid:27860537
  54. 54. Tattevin P, Renault P, Joly V, Bastos R, Coelho E, Adda C, et al. Treatment of latent syphilis in HIV-infected patients with 10 d of benzylpenicillin G benethamine: a prospective study in Maputo, Mozambique. Scand J Infect Dis. 2002;34: 257–261. pmid:12064687
  55. 55. Nnoruka EN, Ezeoke ACJ. Evaluation of syphilis in patients with HIV infection in Nigeria. Trop Med Int Health TM IH. 2005;10: 58–64. pmid:15655014
  56. 56. Modi G, Hari K, Modi M, Mochan A. The frequency and profile of neurology in black South African HIV infected (clade C) patients—a hospital-based prospective audit. J Neurol Sci. 2007;254: 60–64. pmid:17291536